EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Unique brain injury patterns after proton vs photon radiotherapy for WHO grade 2-3 gliomas

Sebastian F Winter iD, Melissa M Gardner, Philipp Karschnia iD, Eugene J Vaios, Clemens Grassberger, Marc R Bussière, Katarina Nikolic, Thanakit Pongpitakmetha, Felix Ehret iD, David Kaul, Wolfgang Boehmerle iD, Matthias Endres iD und 3 weitere

The Oncologist · 2024

DOI: 10.1093/oncolo/oyae195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2024. Verfasst von Sebastian F Winter und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuro-Oncology, Mass General Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, United States. Hauptthemen laut MEDLINE: Proton Therapy, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Berlin Institute of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Central nervous system (CNS) injury following brain-directed radiotherapy remains a major challenge. Proton radiotherapy (PRT) minimizes radiation to healthy brain, potentially limiting sequelae. We characterized CNS radiotoxicity, including radiation-induced leukoencephalopathy (RIL), brain tissue necrosis (TN), and cerebral microbleeds (CMB), in glioma patients treated with PRT or photons (XRT). Patients and Methods Thirty-four patients (19 male; median age 39.6 years) with WHO grade 2-3 gliomas treated with partial cranial radiotherapy (XRT [n = 17] vs PRT[n = 17]) were identified and matched by demographic/clinical criteria. Radiotoxicity was assessed longitudinally for 3 years post-radiotherapy via serial analysis of T2/FLAIR- (for RIL), contrast-enhanced T1- (for TN), and susceptibility (for CMB)-weighted MRI sequences. RIL was rated at whole-brain and hemispheric levels using a novel Fazekas scale-informed scoring system.

Results

The scoring system proved reliable (ICC > 0.85). Both groups developed moderate-to-severe RIL (62%[XRT]; 71%[PRT]) within 3 years; however, XRT was associated with persistent RIL increases in the contralesional hemisphere, whereas contralesional hemispheric RIL plateaued with PRT at 1-year post-radiotherapy (t = 2.180; P = .037). TN rates were greater with PRT (6%[XRT] vs 18%[PRT]; P = ns). CMB prevalence (76%[XRT]; 71%[PRT]) and burden (mean #CMB: 4.0[XRT]; 4.2[PRT]) were similar; however, XRT correlated with greater contralesional hemispheric CMB burden (27%[XRT]; 17%[PRT]; X2 = 4.986; P = .026), whereas PRT-specific CMB clustered at the radiation field margin (X2 = 14.7; P = .002).

Conclusions

CNS radiotoxicity is common and progressive in glioma patients. Injury patterns suggest radiation modality-specificity as RIL, TN, and CMB exhibit unique spatiotemporal differences following XRT vs PRT, likely reflecting underlying dosimetric and radiobiological differences. Familiarity with such injury patterns is essential to improve patient management. Prospective studies are needed to validate these findings and assess their impacts on neurocognitive function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyGliomaBrain NeoplasmsHumansMaleFemaleAdultMiddle AgedRadiation InjuriesPhotonsBrain InjuriesNeoplasm GradingAgedMagnetic Resonance ImagingLeukoencephalopathies

Stichwörter der Autor:innen

complicationsgliomaneurotoxicityprotonsradiation injury

Autor:innen und Institutionen

  • Division of Neuro-Oncology, Mass General Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, United States.
  • Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, 10117 Berlin, Germany.
  • Department of Psychiatry, Psychology Assessment Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, United States.
  • Department of Neurosurgery, Ludwig-Maximilians-University Munich, 81377 Munich, Germany.
  • Department of Radiation Oncology, Duke Cancer Institute, Durham, NC 27710, United States.

ORCID-Profile: Sebastian F Winter, Philipp Karschnia, Felix Ehret, Wolfgang Boehmerle, Matthias Endres

Förderung

  • NCI NIH HHS
  • Berlin Institute of Health
  • National Cancer Institute

Zitieren

APA

Winter, S. F., Gardner, M. M., Karschnia, P., Vaios, E. J., Grassberger, C., Bussière, M. R., Nikolic, K., Pongpitakmetha, T., Ehret, F., Kaul, D., Boehmerle, W., Endres, M., Shih, H. A., Parsons, M. W., & Dietrich, J. (2024). Unique brain injury patterns after proton vs photon radiotherapy for WHO grade 2-3 gliomas. The Oncologist. https://doi.org/10.1093/oncolo/oyae195

Vancouver

Winter SF, Gardner MM, Karschnia P, Vaios EJ, Grassberger C, Bussière MR, et al. Unique brain injury patterns after proton vs photon radiotherapy for WHO grade 2-3 gliomas. The Oncologist. 2024. doi:10.1093/oncolo/oyae195

BibTeX
@article{Winter2024,
  author = {Winter, Sebastian F and Gardner, Melissa M and Karschnia, Philipp and Vaios, Eugene J and Grassberger, Clemens and Bussière, Marc R and Nikolic, Katarina and Pongpitakmetha, Thanakit and Ehret, Felix and Kaul, David and Boehmerle, Wolfgang and Endres, Matthias and Shih, Helen A and Parsons, Michael W and Dietrich, Jorg},
  title = {Unique brain injury patterns after proton vs photon radiotherapy for WHO grade 2-3 gliomas},
  journal = {The Oncologist},
  year = {2024},
  doi = {10.1093/oncolo/oyae195}
}
Kostenlos starten →